Corticotropin-releasing factor overexpression gives rise to sex differences in Alzheimer’s disease-related signaling
Authors:
Open Access
- 18 October 2016
- journal article
- research article
- Published by Springer Nature in Molecular Psychiatry
- Vol. 22 (8) , 1126-1133
Abstract
Several neuropsychiatric and neurodegenerative disorders share stress as a risk factor and are more prevalent in women than in men. Corticotropin-releasing factor (CRF) orchestrates the stress response, and excessive CRF is thought to contribute to the pathophysiology of these diseases. We previously found that the CRF1 receptor (CRF1) is sex biased whereby coupling to its GTP-binding protein, Gs, is greater in females, whereas β-arrestin-2 coupling is greater in males. This study used a phosphoproteomic approach in CRF-overexpressing (CRF-OE) mice to test the proof of principle that when CRF is in excess, sex-biased CRF1 coupling translates into divergent cell signaling that is expressed as different brain phosphoprotein profiles. Cortical phosphopeptides that distinguished female and male CRF-OE mice were overrepresented in unique pathways that were consistent with Gs-dependent signaling in females and β-arrestin-2 signaling in males. Notably, phosphopeptides that were more abundant in female CRF-OE mice were overrepresented in an Alzheimer’s disease (AD) pathway. Phosphoproteomic results were validated by demonstrating that CRF overexpression in females was associated with increased tau phosphorylation and, in a mouse model of AD pathology, phosphorylation of β-secretase, the enzyme involved in the formation of amyloid β. These females exhibited increased formation of amyloid β plaques and cognitive impairments relative to males. Collectively, the findings are consistent with a mechanism whereby the excess CRF that characterizes stress-related diseases initiates distinct cellular processes in male and female brains, as a result of sex-biased CRF1 signaling. Promotion of AD-related signaling pathways through this mechanism may contribute to female vulnerability to AD.Keywords
This publication has 48 references indexed in Scilit:
- Acute Activation of β2-Adrenergic Receptor Regulates Focal Adhesions through βArrestin2- and p115RhoGEF Protein-mediated Activation of RhoAJournal of Biological Chemistry, 2012
- Ephrin regulation of synapse formation, function and plasticityMolecular and Cellular Neuroscience, 2012
- Increased vulnerability of the brain norepinephrine system of females to corticotropin-releasing factor overexpressionMolecular Psychiatry, 2012
- Corticotropin-releasing factor receptor-dependent effects of repeated stress on tau phosphorylation, solubility, and aggregationProceedings of the National Academy of Sciences, 2012
- Chronic Stress Exacerbates Tau Pathology, Neurodegeneration, and Cognitive Performance through a Corticotropin-Releasing Factor Receptor-Dependent Mechanism in a Transgenic Mouse Model of TauopathyJournal of Neuroscience, 2011
- Quantitative Phosphoproteomics of CXCL12 (SDF-1) SignalingPLOS ONE, 2011
- Sex differences in corticotropin-releasing factor receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathologyMolecular Psychiatry, 2010
- Empirical Bayes Analysis of Quantitative Proteomics ExperimentsPLOS ONE, 2009
- Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathiesNature Reviews Drug Discovery, 2009
- Acute stress increases interstitial fluid amyloid-β via corticotropin-releasing factor and neuronal activityProceedings of the National Academy of Sciences, 2007